Hjem › Seglcelle-anæmi › Georgia › Augusta
Seglcelle-anæmi kliniske forsøg i Augusta, GA
5 studier for Seglcelle-anæmi søger deltagere på steder i og omkring Augusta (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekruttererFase 3
- Augusta University Georgia, Augusta
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
RekruttererFase 1
- Augusta University, Augusta
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
RekruttererFase 4
- Augusta University Georgia, Augusta
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
RekruttererFase 1
- Augusta University, Augusta
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
RekruttererObservationsstudie
- Augusta University, Augusta
Seglcelle-anæmi forsøg i andre byer
- Atlanta, GA22 studier
- Washington, DC20 studier
- Memphis, TN18 studier
- Chicago, IL18 studier
- Philadelphia, PA15 studier
- Birmingham, AL14 studier
- New York City, NY13 studier
- St. Louis, MO12 studier
- Durham, NC10 studier
- Cincinnati, OH10 studier
- Houston, TX10 studier
- Boston, MA10 studier
Andre studier i Augusta
- Akut myeloid leukæmi10 studier
- Ægstockræft8 studier
- Livmoderslimhindekræft7 studier
- Kræft (alle typer)7 studier
- Brystkræft5 studier
- Myasthenia gravis4 studier
- Blodcancer4 studier
- Burkitts lymfom4 studier
- Diffust stort B-celle lymfom4 studier
- Kronisk myeloid leukæmi4 studier
- Non-Hodgkin lymfom4 studier
- Livmoderhalskræft4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.